Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid
Clinical trial NCT00437450 · UNKNOWN
Trial details
- NCT number
- NCT00437450
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.